Department of Biotechnology (DBT), Government of India, in association with DBT/Wellcome Trust India Alliance, organised a series of webinars to provide an overview of DBT’s multi-pronged response to COVID-19 pandemic. The fourth webinar, with a focus on the response of the DBT’s Autonomous Institutes to fight COVID-19 pandemic, was organised on September 11, 2020.
DBT’s Autonomous Institutes are actively involved in the country’s fight against COVID-19 through the development of diagnostics, vaccines, and drugs.
This webinar aims to focus on the efforts of National Institute of Immunology (NII), Institute of Life Sciences (ILS) and Institute of Bioresources and Sustainable Development (IBSD) in the development of diagnostics, vaccines, and drugs.
The panellists are:
– Dr Amulya Panda, Director, National Institute of Immunology, New Delhi
– Dr Ajay Kumar Parida, Director, Institute of Life Sciences, Bhubaneshwar
– Prof Pulok Mukherjee, Director, Institute of Bioresources and Sustainable Development, Imphal
To find out more about DBT’s COVID-19 efforts, please visit:
